Cian Healthcare Ltd vs Haleos Labs Limited Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Cian Healthcare Ltd is ₹ 8.26 as of 10 Apr 15:30 . The P/E Ratio of Cian Healthcare Ltd changed from 562.5 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Haleos Labs Limited changed from 11 on March 2021 to 16.2 on March 2025 . This represents a CAGR of 8.05% over 5 years The Market Cap of Cian Healthcare Ltd changed from ₹ 26.28 crore on March 2021 to ₹ 8.62 crore on March 2025 . This represents a CAGR of -19.98% over 5 yearsThe Market Cap of Haleos Labs Limited changed from ₹ 149.61 crore on March 2021 to ₹ 326.64 crore on March 2025 . This represents a CAGR of 16.90% over 5 years The revenue of Cian Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Haleos Labs Limited for the Dec '25 is ₹ 94.97 crore as compare to the Sep '25 revenue of ₹ 81.79 crore. This represent the growth of 16.11% The ebitda of Cian Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Haleos Labs Limited for the Dec '25 is ₹ 14.23 crore as compare to the Sep '25 ebitda of ₹ 13.99 crore. This represent the growth of 1.72% The net profit of Cian Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Haleos Labs Limited changed from ₹ 7.1 crore to ₹ 6.65 crore over 7 quarters. This represents a CAGR of -3.67% The Dividend Payout of Cian Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Haleos Labs Limited changed from 3.44 % on March 2021 to 2.12 % on March 2025 . This represents a CAGR of -9.23% over 5 years .

About Cian Healthcare Ltd

Cian Healthcare Limited was originally incorporated as a Private Limited Company with the name of 'Cian Healthcare Private Limited' on January 07, 2003.
Subsequently, the Company was converted into a Public Limited Company and the name of the Company was changed to 'Cian Healthcare Limited' pursuant to a fresh Certificate of Incorporation granted by the Registrar of Companies, Pune dated November 30, 2018. The Company is a certified transnational manufacturing Company with wide range of Pharmaceutical, Nutraceutical, Ayurvedic, Cosmeceuticals, Sexual Wellness and Food supplement products.
The Company complies with the standard manufacturing practices as laid down by the World Health Organization and is also certified by the Food and Drug Control Administration. The Company started manufacturing unit at Roorkee in Uttarakhand in 2013.

About Haleos Labs Limited

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006.
The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector.
The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates.
The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments.

FAQs for the comparison of Cian Healthcare Ltd and Haleos Labs Limited

Which company has a larger market capitalization, Cian Healthcare Ltd or Haleos Labs Limited?

Market cap of Cian Healthcare Ltd is 20 Cr while Market cap of Haleos Labs Limited is 483 Cr

What are the key factors driving the stock performance of Cian Healthcare Ltd and Haleos Labs Limited?

The stock performance of Cian Healthcare Ltd and Haleos Labs Limited is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Cian Healthcare Ltd and Haleos Labs Limited?

As of May 18, 2026, the Cian Healthcare Ltd stock price is INR ₹8.26. On the other hand, Haleos Labs Limited stock price is INR ₹1600.0.

How do dividend payouts of Cian Healthcare Ltd and Haleos Labs Limited compare?

To compare the dividend payouts of Cian Healthcare Ltd and Haleos Labs Limited, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.